| AMCZX | PEMGX | AMCZX / PEMGX | |
| Total Expense Ratio | 0.79 | 0.90 | 88% |
| Annual Report Gross Expense Ratio | 0.92 | 0.90 | 102% |
| Fund Existence | 11 years | 21 years | - |
| Gain YTD | 4.169 | -4.591 | -91% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 500000 | 1000 | 50,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 294M | 23.1B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 8.16 | -14.48 | -56% |
| Returns for 3 years | 49.46 | 11.28 | 438% |
| Returns for 5 years | -14.65 | -5.82 | 252% |
| Returns for 10 years | 90.04 | 76.25 | 118% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ESGV | 132.02 | 0.89 | +0.68% |
| Vanguard ESG US Stock ETF | |||
| SPMV | 50.75 | N/A | N/A |
| Invesco S&P 500 Minimum Variance ETF | |||
| BNDP | 73.11 | -0.17 | -0.23% |
| Vanguard Core-Plus Bond Index ETF | |||
| NIM | 9.16 | -0.03 | -0.33% |
| Nuveen Select Maturities Municipal Fund | |||
| HQL | 19.10 | -0.34 | -1.75% |
| abrdn Life Sciences Investors | |||